Works matching AU Cooper, Mark E.

Results: 258

Effect of diabetes and aminoguanidine therapy on renal advanced glycation end-product binding.

Published in:

Kidney International, 1999, v. 55, n. 3, p. 907, doi. 10.1046/j.1523-1755.1999.055003907.x

By:

YOUSSEF, SHERIF;
NGUYEN, DOMINIQUE T.;
SOULIS, TINA;
PANAGIOTOPOULOS, SIANNA;
JERUMS, GEORGE;
COOPER, MARK E.;
Cooper, Mark E.

Publication type:

Article

PPAR-α and -γ agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.

Published in:

Nephrology Dialysis Transplantation, 2006, v. 21, n. 9, p. 2399, doi. 10.1093/ndt/gfl212

By:

Anna C. Calkin;
Sara Giunti;
Karin A. Jandeleit-Dahm;
Terri J. Allen;
Mark E. Cooper;
Merlin C. Thomas

Publication type:

Article

Renoprotective and anti‐hypertensive effects of combined valsartan and perindopril in progressive diabetic nephropathy in the transgenic (mRen‐2)27 rat.

Published in:

Nephrology Dialysis Transplantation, 2001, v. 16, n. 7, p. 1343

By:

Wilkinson‐Berka, Jennifer L.;
Gibbs, Narelle J.;
Cooper, Mark E.;
Skinner, Sandford L.;
Kelly, Darren J.

Publication type:

Article

Aminoguanidine ameliorates changes in the IGF system in experimental diabetic nephropathy.

Published in:

Nephrology Dialysis Transplantation, 2000, v. 15, n. 3, p. 347, doi. 10.1093/ndt/15.3.347

By:

Bach, Leon A.;
Dean, Rachael;
Youssef, Sherrif;
Cooper, Mark E.

Publication type:

Article

Elevated Fasting Blood Glucose Levels Are Associated with Worse Clinical Outcomes in COVID-19 Patients Than in Pneumonia Patients with Bacterial Infections.

Published in:

Pathogens, 2022, v. 11, n. 8, p. 902, doi. 10.3390/pathogens11080902

By:

Wang, Wenjun;
Chai, Zhonglin;
Cooper, Mark E;
Zimmet, Paul Z;
Guo, Hua;
Ding, Junyu;
Yang, Feifei;
Lin, Xixiang;
Chen, Xu;
Wang, Xiao;
Zhong, Qin;
Li, Zongren;
Zhang, Peifang;
Wu, Zhenzhou;
Guan, Xizhou;
Zhang, Lei;
He, Kunlun

Publication type:

Article

Erratum to: Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes (t2d): the carmelina randomised controlled trial.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 9, p. 2136, doi. 10.1093/ckj/sfab104

By:

Wanner, Christoph;
Cooper, Mark E;
Johansen, Odd Erik;
Toto, Robert;
Rosenstock, Julio;
McGuire, Darren K;
Kahn, Steven E;
Pfarr, Egon;
Schnaidt, Sven;
Eynatten, Maximilian von;
George, Jyothis T;
Gollop, Nicholas D;
Marx, Nikolaus;
Alexander, John H;
Zinman, Bernard;
Perkovic, Vlado

Publication type:

Article

Effect of linagliptin versus placebo on cardiovascular and kidney outcomes in nephrotic-range proteinuria and type 2 diabetes: the CARMELINA randomized controlled trial.

Published in:

Clinical Kidney Journal, 2021, v. 14, p. 226, doi. 10.1093/ckj/sfaa225

By:

Wanner, Christoph;
Cooper, Mark E;
Johansen, Odd Erik;
Toto, Robert;
Rosenstock, Julio;
McGuire, Darren K;
Kahn, Steven E;
Pfarr, Egon;
Schnaidt, Sven;
Eynatten, Maximilian von;
George, Jyothis T;
Gollop, Nicholas D;
Marx, Nikolaus;
Alexander, John H;
Zinman, Bernard;
Perkovic, Vlado;
investigators, the CARMELINA

Publication type:

Article

Clinical and Pathological Features of Chinese Patients with Type 2 Diabetes, Biopsy-Proven Diabetic Kidney Disease, and Rapid eGFR Decline.

Published in:

Diabetes, Metabolic Syndrome & Obesity: Targets & Therapy, 2022, v. 15, p. 2847, doi. 10.2147/DMSO.S381052

By:

Qin, Chunmei;
Wang, Yiting;
Zhao, Lijun;
Zhang, Junlin;
Ren, Honghong;
Zou, Yutong;
Wu, Yucheng;
Wang, Tingli;
Zhao, Yuancheng;
Zhang, Rui;
Xu, Huan;
Zhang, Jie;
Cooper, Mark E;
Liu, Fang

Publication type:

Article

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

Published in:

2014

By:

Wang, Bo;
Jha, Jay C;
Hagiwara, Shinji;
McClelland, Aaron D;
Jandeleit-Dahm, Karin;
Thomas, Merlin C;
Cooper, Mark E;
Kantharidis, Phillip

Publication type:

journal article

Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b.

Published in:

Kidney International, 2014, v. 85, n. 2, p. 352, doi. 10.1038/ki.2013.372

By:

Wang, Bo;
Jha, Jay C;
Hagiwara, Shinji;
McClelland, Aaron D;
Jandeleit-Dahm, Karin;
Thomas, Merlin C;
Cooper, Mark E;
Kantharidis, Phillip

Publication type:

Article

Report on ISN Forefronts, Melbourne, Australia, 4-7 October 2012: tubulointerstitial disease in diabetic nephropathy.

Published in:

Kidney International, 2013, v. 84, n. 4, p. 653, doi. 10.1038/ki.2013.89

By:

Forbes, Josephine M;
Harris, David C H;
Cooper, Mark E

Publication type:

Article

Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.

Published in:

Kidney International, 2013, v. 83, n. 3, p. 517, doi. 10.1038/ki.2012.401

By:

Perkovic, Vlado;
Heerspink, Hiddo Lambers;
Chalmers, John;
Woodward, Mark;
Jun, Min;
Li, Qiang;
MacMahon, Stephen;
Cooper, Mark E;
Hamet, Pavel;
Marre, Michel;
Mogensen, Carl Erik;
Poulter, Neil;
Mancia, Giuseppe;
Cass, Alan;
Patel, Anushka;
Zoungas, Sophia

Publication type:

Article

An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function.

Published in:

Kidney International, 2011, v. 80, n. 3, p. 282, doi. 10.1038/ki.2011.79

By:

Holtkamp, Frank A.;
de Zeeuw, Dick;
Thomas, Merlin C.;
Cooper, Mark E.;
de Graeff, Pieter A.;
Hillege, Hans J. L.;
Parving, Hans-Henrik;
Brenner, Barry M.;
Shahinfar, Shahnaz;
Lambers Heerspink, Hiddo J.

Publication type:

Article

Targeted reduction of advanced glycation improves renal function in obesity.

Published in:

Kidney International, 2011, v. 80, n. 2, p. 190, doi. 10.1038/ki.2011.57

By:

Harcourt, Brooke E.;
Sourris, Karly C.;
Coughlan, Melinda T.;
Walker, Karen Z.;
Dougherty, Sonia L.;
Andrikopoulos, Sofianos;
Morley, Amy L.;
Bonke, Vicki Thallas;
Chand, Vibhasha;
Penfold, Sally A.;
de Courten, Maximilian P. J.;
Thomas, Merlin C.;
Kingwell, Bronwyn A.;
Bierhaus, Angelika;
Cooper, Mark E.;
de Courten, Barbora;
Forbes, Josephine M.

Publication type:

Article

Cell division autoantigen 1 enhances signaling and the profibrotic effects of transforming growth factor-β in diabetic nephropathy.

Published in:

Kidney International, 2011, v. 79, n. 2, p. 199, doi. 10.1038/ki.2010.374

By:

Yugang Tu;
Tieqiao Wu;
Aozhi Dai;
Yen Pham;
Chew, Phyllis;
Haan, Judy B. de;
Yu Wang;
Toh, Ban-Hock;
Hongjian Zhu;
Zemin Cao;
Cooper, Mark E.;
Zhonglin Chai

Publication type:

Article

Circulating high-molecular-weight RAGE ligands activate pathways implicated in the development of diabetic nephropathy.

Published in:

Kidney International, 2010, v. 78, n. 3, p. 287, doi. 10.1038/ki.2010.134

By:

Penfold, Sally A.;
Coughlan, Melinda T.;
Patel, Sheila K.;
Srivastava, Piyush M.;
Sourris, Karly C.;
Steer, David;
Webster, Diane E.;
Thomas, Merlin C.;
MacIsaac, Richard J.;
Jerums, George;
Burrell, Louise M.;
Cooper, Mark E.;
Forbes, Josephine M.

Publication type:

Article

Targets to retard the progression of diabetic nephropathy.

Published in:

Kidney International, 2005, v. 68, n. 4, p. 1439, doi. 10.1111/j.1523-1755.2005.00555.x

By:

Cooper, Mark E.;
Jandeleit-Dahm, Karin;
Thomas, Merlin C.

Publication type:

Article

Increased tubular organic ion clearance following chronic ACE inhibition in patients with type 1 diabetes.

Published in:

Kidney International, 2005, v. 67, n. 6, p. 2494, doi. 10.1111/j.1523-1755.2005.00359.x

By:

Thomas, Merlin C.;
Jerums, George;
Tsalamandris, Con;
MacIsaac, Richard;
Panagiotopoulos, Sianna;
Cooper, Mark E.

Publication type:

Article

AGEs activate mesangial TGF-β–Smad signaling via an angiotensin II type I receptor interaction.

Published in:

Kidney International, 2004, v. 66, n. 6, p. 2137, doi. 10.1111/j.1523-1755.2004.66004.x

By:

Fukami, Kei;
Ueda, Seiji;
Yamagishi, Sho-ichi;
Kato, Seiya;
Inagaki, Yosuke;
Takeuchi, Masayoshi;
Motomiya, Yoshihiro;
Bucala, Richard;
Iida, Shuji;
Tamaki, Kiyoshi;
Imaizumi, Tsutomu;
Cooper, Mark E.;
Okuda, Seiya

Publication type:

Article

The effects of valsartan on the accumulation of circulating and renal advanced glycation end products in experimental diabetes.

Published in:

Kidney International, 2004, v. 66, p. S105, doi. 10.1111/j.1523-1755.2004.09225.x

By:

Forbes, Josephine M.;
Thomas, Merlin C.;
Thorpe, Suzanne R.;
Alderson, Nathan L.;
Cooper, Mark E.

Publication type:

Article

Calcium channel blockers, either amlodipine or mibefradil, ameliorate renal injury in experimental diabetes.

Published in:

Kidney International, 2004, v. 66, n. 3, p. 1090, doi. 10.1111/j.1523-1755.2004.00859.x

By:

Ma, Guorong;
Allen, Terri J.;
Cooper, Mark E.;
Cao, Zemin

Publication type:

Article

Low-molecular-weight AGEs are associated with GFR and anemia in patients with type 2 diabetes.

Published in:

Kidney International, 2004, v. 66, n. 3, p. 1167, doi. 10.1111/j.1523-1755.2004.00868.x

By:

Thomas, Merlin C.;
Tsalamandris, Con;
MacIsaac, Richard;
Medley, Tanya;
Kingwell, Bronwyn;
Cooper, Mark E.;
Jerums, George

Publication type:

Article

Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL.

Published in:

Kidney International, 2004, v. 65, n. 6, p. 2309, doi. 10.1111/j.1523-1755.2004.00653.x

By:

De Zeeuw, Dick;
Remuzzi, Giuseppe;
Parving, Hans-Henrik;
Keane, William F.;
Zhongxin Zhang;
Shahinfar, Shahnaz;
Snapinn, Steve;
Cooper, Mark E.;
Mitch, William F.;
Brenner, Barry M.

Publication type:

Article

Effects of the combination of an angiotensin II antagonist with an HMG-CoA reductase inhibitor in experimental diabetes.

Published in:

Kidney International, 2003, v. 64, n. 2, p. 565, doi. 10.1046/j.1523-1755.2003.00127.x

By:

Qin, Jie;
Zhang, Zhili;
Liu, Jie;
Sun, Liao;
Hu, Ling;
Cooper, Mark E.;
Cao, Zemin

Publication type:

Article

Reduced tubular cation transport in diabetes: Prevented by ACE inhibition.

Published in:

Kidney International, 2003, v. 63, n. 6, p. 2152, doi. 10.1046/j.1523-1755.2003.00006.x

By:

Thomas, Merlin C.;
Tikellis, Chris;
Burns, Wendy C.;
Thallas, Vicki;
Forbes, Josephine M.;
Cao, Zemin;
Osicka, Tanya M.;
Russo, Leileata M.;
Jerums, George;
Ghabrial, Hany;
Cooper, Mark E.;
Kantharidis, Phillip

Publication type:

Article

Induction of MIF synthesis and secretion by tubular epithelial cells: a novel action of angiotensin II.

Published in:

2003

By:

Rice, Edwina K.;
Tesch, Gregory H.;
Cao, Zemin;
Cooper, Mark E.;
Metz, Christine N.;
Bucala, Richard;
Atkins, Robert C.;
Nikolic-Paterson, David J.

Publication type:

journal article

Dialysis delayed is death prevented: A clinical perspective on the RENAAL study.

Published in:

Kidney International, 2003, v. 63, n. 4, p. 1577, doi. 10.1046/j.1523-1755.2003.00893.x

By:

Thomas, Merlin C.;
Cooper, Mark E.;
Shahinfar, Shahnaz;
Brenner, Barry M.

Publication type:

Article

Interactions between growth factors in the kidney: Implications for progressive renal injury.

Published in:

2003

By:

Cooper, Mark E.;
Thomas, Merlin C.

Publication type:

Editorial

Calcitonin receptor isoforms expressed in the developing rat kidney.

Published in:

Kidney International, 2003, v. 63, n. 2, p. 416, doi. 10.1046/j.1523-1755.2003.00754.x

By:

Tikellis, Christos;
Xuereb, Loredanna;
Casley, David;
Brasier, Geoffrey;
Cooper, Mark E.;
Wookey, Peter J.

Publication type:

Article

Renal ischemia-reperfusion increases endothelial VEGFR-2 without increasing VEGF or VEGFR-1 expression.

Published in:

Kidney International, 2002, v. 61, n. 5, p. 1696, doi. 10.1046/j.1523-1755.2002.00329.x

By:

Kanellis, John;
Paizis, Kathy;
Cox, Alison J;
Stacker, Steven A;
Gilbert, Richard E;
Cooper, Mark E;
Power, David A

Publication type:

Article

Attenuation of tubular apoptosis by blockade of the renin-angiotensin system in diabetic Ren-2 rats.

Published in:

Kidney International, 2002, v. 61, n. 1, p. 31, doi. 10.1046/j.1523-1755.2002.00088.x

By:

Kelly, Darren J.;
Cox, Alison J.;
Tolcos, Mary;
Cooper, Mark E.;
Wilkinson-Berka, Jennifer L.;
Gilbert, Richard E.

Publication type:

Article

Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.

Published in:

Kidney International, 2001, v. 60, n. 2, p. 715, doi. 10.1046/j.1523-1755.2001.060002715.x

By:

Cao, Zemin;
Burrell, Louise M.;
Tikkanen, Ilkka;
Bonnet, Fabrice;
Cooper, Mark E.;
Gilbert, Richard E.

Publication type:

Article

Experimental Models of Type-2 Diabetic Nephropathy.

Published in:

Experimental Diabetes Research, 2012, p. 1, doi. 10.1155/2012/218917

By:

Tomino, Yasuhiko;
Cooper, Mark E.;
Kurtz, Theodore W.;
Shimizu, Yoshio

Publication type:

Article

Targeted deletion of nicotinamide adenine dinucleotide phosphate oxidase 4 from proximal tubules is dispensable for diabetic kidney disease development.

Published in:

Nephrology Dialysis Transplantation, 2021, v. 36, n. 6, p. 988, doi. 10.1093/ndt/gfaa376

By:

Thallas-Bonke, Vicki;
Tan, Sih Min;
Lindblom, Runa S;
Snelson, Matthew;
Granata, Cesare;
Jha, Jay Chandra;
Sourris, Karly C;
Laskowski, Adrienne;
Watson, Anna;
Tauc, Michel;
Rubera, Isabelle;
Zheng, Guoping;
Shah, Ajay M;
Harris, David C H;
Elbatreek, Mahmoud H;
Kantharidis, Phillip;
Cooper, Mark E;
Jandeleit-Dahm, Karin;
Coughlan, Melinda T

Publication type:

Article

Choice of endpoint in kidney outcome trials: considerations from the EMPA-REG OUTCOME<sup>®</sup> trial.

Published in:

Nephrology Dialysis Transplantation, 2020, v. 35, n. 12, p. 2103, doi. 10.1093/ndt/gfz179

By:

Perkovic, Vlado;
Koitka-Weber, Audrey;
Cooper, Mark E;
Schernthaner, Guntram;
Pfarr, Egon;
Woerle, Hans J;
Eynatten, Maximilian von;
Wanner, Christoph

Publication type:

Article

Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.

Published in:

Nephrology Dialysis Transplantation, 2013, v. 28, n. 1, p. 55, doi. 10.1093/ndt/gfs387

By:

Takamiya, Yoshimi;
Fukami, Kei;
Yamagishi, Sho-ichi;
Kaida, Yusuke;
Nakayama, Yosuke;
Obara, Nana;
Iwatani, Ryuji;
Ando, Ryotaro;
Koike, Kiyomi;
Matsui, Takanori;
Nishino, Yuri;
Ueda, Seiji;
Cooper, Mark E.;
Okuda, Seiya

Publication type:

Article

Metabolic memory: implications for diabetic vascular complications.

Published in:

Pediatric Diabetes, 2009, v. 10, n. 5, p. 343, doi. 10.1111/j.1399-5448.2008.00491.x

By:

Cooper, Mark E.

Publication type:

Article

Is diabetic nephropathy disappearing from clinical practice?

Published in:

2006

By:

Cooper, Mark E.

Publication type:

Editorial

Extracellular matrix, growth factors and their interactions in the pathogenesis of diabetic kidney disease.

Published in:

Nephrology, 1996, v. 2, n. 5, p. 291, doi. 10.1111/j.1440-1797.1996.tb00105.x

By:

GILBERT, Richard E;
COOPER, Mark E;
JERUMS, George

Publication type:

Article

Disparate Effects of Diabetes and Hyperlipidemia on Experimental Kidney Disease.

Published in:

Frontiers in Physiology, 2020, v. 11, p. 1, doi. 10.3389/fphys.2020.00518

By:

Watson, Anna M. D.;
Gould, Eleanor A. M.;
Moody, Sarah C.;
Sivakumaran, Priyadharshini;
Sourris, Karly C.;
Chow, Bryna S. M.;
Koïtka-Weber, Audrey;
Allen, Terri J.;
Jandeleit-Dahm, Karin A. M.;
Cooper, Mark E.;
Calkin, Anna C.

Publication type:

Article

Effect of Linagliptin vs Placebo on Major Cardiovascular Events in Adults With Type 2 Diabetes and High Cardiovascular and Renal Risk: The CARMELINA Randomized Clinical Trial.

Published in:

2019

By:

Rosenstock, Julio;
Perkovic, Vlado;
Johansen, Odd Erik;
Cooper, Mark E.;
Kahn, Steven E.;
Marx, Nikolaus;
Alexander, John H.;
Pencina, Michael;
Toto, Robert D.;
Wanner, Christoph;
Zinman, Bernard;
Woerle, Hans Juergen;
Baanstra, David;
Pfarr, Egon;
Schnaidt, Sven;
Meinicke, Thomas;
George, Jyothis T.;
von Eynatten, Maximilian;
McGuire, Darren K.;
CARMELINA Investigators

Publication type:

journal article

Type 2 diabetes in Asia: Like chronic obstructive pulmonary disease, a threat to human health and wellbeing (亚洲2型糖尿病：像慢性阻塞性肺病一样威胁人类的健康与幸福)

Published in:

Journal of Diabetes, 2014, v. 6, n. 2, p. 120, doi. 10.1111/1753-0407.12097

By:

Cooper, Mark E.;
Rebuck, Anthony S.

Publication type:

Article

Is clinical trial data showing positive progress for the treatment of diabetic kidney disease?

Published in:

2023

By:

Tan, Seng Kiong;
Cooper, Mark E.

Publication type:

Editorial

Kidney Disease: The Forgotten Legacy of Type 1 Diabetes.

Published in:

Diabetes Care, 2025, v. 48, n. 8, p. 1299, doi. 10.2337/dci25-0028

By:

Thomas, Merlin C.;
Zoungas, Sophia;
Hanssen, Nordin M.J.;
McAuley, Sybil A.;
Cooper, Mark E.

Publication type:

Article

Contemporary Management of Heart Failure in Patients With Diabetes.

Published in:

2020

By:

Shaw, James A.;
Cooper, Mark E.

Publication type:

journal article

Effects of Linagliptin on Cardiovascular and Kidney Outcomes in People With Normal and Reduced Kidney Function: Secondary Analysis of the CARMELINA Randomized Trial.

Published in:

2020

By:

Perkovic, Vlado;
Toto, Robert;
Cooper, Mark E.;
Mann, Johannes F.E.;
Rosenstock, Julio;
McGuire, Darren K.;
Kahn, Steven E.;
Marx, Nikolaus;
Alexander, John H.;
Zinman, Bernard;
Pfarr, Egon;
Schnaidt, Sven;
Meinicke, Thomas;
von Eynatten, Maximillian;
George, Jyothis T.;
Johansen, Odd Erik;
Wanner, Christoph;
CARMELINA investigators

Publication type:

journal article

Cardiac Stress and Inflammatory Markers as Predictors of Heart Failure in Patients With Type 2 Diabetes: The ADVANCE Trial.

Published in:

2017

By:

Toshiaki Ohkuma;
Min Jun;
Woodward, Mark;
Zoungas, Sophia;
Cooper, Mark E.;
Grobbee, Diederick E.;
Hamet, Pavel;
Mancia, Giuseppe;
Williams, Bryan;
Welsh, Paul;
Sattar, Naveed;
Shaw, Jonathan E.;
Rahimi, Kazem;
Chalmers, John;
Ohkuma, Toshiaki;
Jun, Min;
ADVANCE Collaborative Group

Publication type:

journal article

Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON.

Published in:

2016

By:

Wong, Muh Geot;
Perkovic, Vlado;
Chalmers, John;
Woodward, Mark;
Qiang Li;
Cooper, Mark E.;
Hamet, Pavel;
Harrap, Stephen;
Heller, Simon;
MacMahon, Stephen;
Mancia, Giuseppe;
Marre, Michel;
Matthews, David;
Neal, Bruce;
Poulter, Neil;
Rodgers, Anthony;
Williams, Bryan;
Zoungas, Sophia;
Li, Qiang;
ADVANCE-ON Collaborative Group

Publication type:

journal article

Relationship between levels of advanced glycation end products and their soluble receptor and adverse outcomes in adults with type 2 diabetes.

Published in:

2015

By:

Thomas, Merlin C.;
Woodward, Mark;
Neal, Bruce;
Qiang Li;
Pickering, Raelene;
Marre, Michel;
Williams, Bryan;
Perkovic, Vlado;
Cooper, Mark E.;
Zoungas, Sophia;
Chalmers, John;
Hillis, Graham S.;
Li, Qiang;
ADVANCE Collaborative Group

Publication type:

journal article

Linagliptin lowers albuminuria on top of recommended standard treatment in patients with type 2 diabetes and renal dysfunction.

Published in:

2013

By:

Groop, Per-Henrik;
Cooper, Mark E;
Perkovic, Vlado;
Emser, Angela;
Woerle, Hans-Juergen;
von Eynatten, Maximilian

Publication type:

journal article